Targeted Monitoring Triggered by Protocol Deviations
Targeted Monitoring Triggered by Protocol Deviations How Protocol Deviations Trigger Targeted Monitoring in Clinical Trials Introduction: When Deviations Signal Oversight Gaps Protocol deviations are more than isolated compliance errors—they often serve as early warning signals of systemic gaps in clinical trial conduct. Regulatory agencies such as the FDA, EMA, and MHRA increasingly expect sponsors to…
Read More “Targeted Monitoring Triggered by Protocol Deviations” »